Prulifloxacin


Thông tin thuốc gốc
Chỉ định và Liều dùng
Oral
Acute uncomplicated urinary tract infections
Adult: 600 mg as a single dose. Treatment or dosage recommendations may vary among countries or individual products (refer to specific product or local treatment guidelines).

Oral
Acute exacerbations of chronic bronchitis, Complicated lower urinary tract infections
Adult: 600 mg once daily for up to a Max of 10 days, depending on the severity of the disease and clinical outcome. Treatment or dosage recommendations may vary among countries or individual products (refer to specific product or local treatment guidelines).
Chống chỉ định
Hypersensitivity to prulifloxacin or other quinolone antibacterials. Coeliac disease, anamnesis of tendon diseases related to the administration of quinolones. Children or adolescents below 18 years with uncomplicated skeletal development. Pregnancy and lactation. Concomitant use with fenbufen or flurbiprofen.
Thận trọng
Patient with CNS disorders that may predispose to convulsion or lower the convulsion threshold; remarkably low stomach acid state (e.g. achlorhydria), hypokalaemia, hypocalcaemia, rhythm disorders, latent or known G6PD deficiency. Renal impairment.
Tác dụng không mong muốn
Significant: Phototoxicity, shock or anaphylactoid reaction, crystalluria, hypoglycaemia, pseudomembranous colitis. Rarely, rhabdomyolysis and rapid deterioration of renal function.
Ear and labyrinth disorders: Impaired hearing.
Eye disorders: Ocular hyperaemia.
Gastrointestinal disorders: Abdominal pain, altered taste, epigastralgia, nausea, diarrhoea, gastritis, vomiting.
General disorders and administration site conditions: Fever.
Investigations: Increased AST/ALT.
Metabolism and nutrition disorders: Anorexia.
Musculoskeletal and connective tissue disorders: Muscle spasms.
Nervous system disorders: Cephalalgia, dizziness, drowsiness, lightheadedness.
Psychiatric disorders: Sleep disorders.
Skin and subcutaneous tissue disorders: Pruritus, rash.
Thông tin tư vấn bệnh nhân
Avoid excessive exposure to sunlight or UV rays. Maintain adequate water balance.
Tương tác
May enhance the effects of theophylline. May reduce absorption with antacids containing Al or Mg, Fe or Ca preparations, H2-receptor antagonists (e.g. cimetidine), PPIs (e.g. omeprazole).
Potentially Fatal: Convulsions may occur with concomitant use of fenbufen or flurbiprofen.
Tác dụng
Description: Prulifloxacin is the prodrug of ulifloxacin, a fluoroquinolone antibacterial with properties similar to those of ciprofloxacin. Upon conversion to ulifloxacin, it is transferred into bacterial cells in high concentration and exhibits antibacterial activity by inhibiting the activity of deoxyribonucleic acid (DNA) gyrase. It has a broad antibacterial spectrum against both gram-positive and gram-negative bacteria.
Pharmacokinetics:
Absorption: Time to peak plasma concentration: 1 hour.
Distribution: Extensively distributed throughout body tissues. Volume of distribution: 1,231 L. Plasma protein binding: Approx 45%.
Metabolism: Metabolised mainly to ulifloxacin in intestinal tissue, portal vein and liver; undergoes extensive first-pass metabolism.
Excretion: Via urine (as unchanged drug). Elimination half-life: 10.6-12.1 hours.
Đặc tính

Chemical Structure Image
Prulifloxacin

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 65947, Prulifloxacin. https://pubchem.ncbi.nlm.nih.gov/compound/Prulifloxacin. Accessed Feb. 22, 2022.

Bảo quản
Store below 30°C.
Phân loại MIMS
Quinolon
Phân loại ATC
J01MA17 - prulifloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Tài liệu tham khảo
Anon. Prulifloxacin. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 16/11/2021.

Buckingham R (ed). Prulifloxacin. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 16/11/2021.

Darflox (Meiji). MIMS Thailand. http://www.mims.com/thailand. Accessed 16/11/2021.

Prulibact 600 mg Film-Coated Tablet (Micro Labs Limited). MIMS Philippines. http://www.mims.com/philippines. Accessed 16/11/2021.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Prulifloxacin từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2022 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in